Average Co-Inventor Count = 4.76
ph-index = 12
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Merck Sharp + Dohme Corp. (36 from 2,405 patents)
2. Merck + Co., Inc. (8 from 4,770 patents)
3. Astex Therapeutics Limited (5 from 123 patents)
4. Merck Sharpe & Dohme Corp. (1 from 35 patents)
5. Dohme Ltd. (1 from 1 patent)
6. Merck Sharp (1 from 1 patent)
51 patents:
1. 9428439 - Hydrobenzamide derivatives as inhibitors of Hsp90
2. 8796244 - Imidazopyridine derivatives as inhibitors of receptor tyrosine kinases
3. 8664218 - Pharmaceutical compounds
4. 8653084 - Hydrobenzamide derivatives as inhibitors of Hsp90
5. 8383619 - Pharmaceutical compounds
6. 7598386 - Sulphones which modulate the action of gamma-secretase
7. 7595344 - Sulphones which modulate the action of gamma secretase
8. 7410964 - Cyclohexyl sulphones as gamma-secretase inhibitors
9. 7342009 - Cyclic sulfonamides for inhibition of gamma-secretase
10. 7304094 - Cyclohexyl sulphones
11. 7265110 - Tetrahydropyran derivatives and their use as therapeutic agents
12. 7138400 - Sulfamides as gamma-secretase inhibitors
13. 6984663 - Cyclohexyl sulphones
14. 6964981 - Tetrahydrofuran derivatives and their use as NK-1 antagonists
15. 6638930 - Morpholine and thiomorpholine tachykinin receptor antagonists